Literature DB >> 28405833

Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer.

Francesca Giunchi1, Kristina Jordahl2, Enrico Bollito3, Maurizio Colecchia4, Carlo Patriarca5, Antonietta D'Errico1, Francesco Vasuri1, Deborah Malvi1, Alessandro Fornari3, Luca Reggiani Bonetti6, Barbara Corti1, Mauro Papotti7, Paolo DeGiuli8, Massimo Loda9, Rodolfo Montironi10, Michelangelo Fiorentino11, Jennifer R Rider2,12.   

Abstract

Epidemiological and biological evidence indicates a causal relationship between the presence of proliferative atrophic lesions and the development of prostatic intraepithelial neoplasia (PIN) and prostate cancer. The presence of inflammatory and atrophic lesions of the prostate is widely underestimated and they are not generally mentioned in pathology reports. We performed a histopathological concordance study among eight genitourinary specialists and seven generalist pathologists, using 116 histological slides of prostate lesions, including proliferative atrophic lesions, PIN, and cancer. The overall agreement between all possible pairs of reviewers was 80% for prostate cancer, 67% for PIN, and 49% for proliferative atrophic lesions. When using as gold standard the assessment of a single genitourinary pathologist, the mean agreement percentage increased to 97% for prostate cancer, 92% for PIN, and 72% for proliferative atrophic lesions.

Entities:  

Keywords:  Atrophic lesions; Inflammation; PAH; Prostate

Mesh:

Year:  2017        PMID: 28405833     DOI: 10.1007/s00428-017-2123-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

Review 1.  Prostate cancer.

Authors:  William G Nelson; Angelo M De Marzo; William B Isaacs
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

2.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Standardization of Gleason grading among 337 European pathologists.

Authors:  Lars Egevad; Amar S Ahmad; Ferran Algaba; Daniel M Berney; Liliane Boccon-Gibod; Eva Compérat; Andrew J Evans; David Griffiths; Rainer Grobholz; Glen Kristiansen; Cord Langner; Antonio Lopez-Beltran; Rodolfo Montironi; Sue Moss; Pedro Oliveira; Ben Vainer; Murali Varma; Philippe Camparo
Journal:  Histopathology       Date:  2013-01       Impact factor: 5.087

Review 4.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

5.  Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.

Authors:  Tytti H Yli-Hemminki; Marita Laurila; Anssi Auvinen; Liisa Määttänen; Heini Huhtala; Teuvo L J Tammela; Paula M Kujala
Journal:  BJU Int       Date:  2013-06-07       Impact factor: 5.588

Review 6.  Inflammation in prostate carcinogenesis.

Authors:  Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

7.  Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.

Authors:  Daniel M Moreira; J Curtis Nickel; Leah Gerber; Roberto L Muller; Gerald L Andriole; Ramiro Castro-Santamaria; Stephen J Freedland
Journal:  Cancer       Date:  2013-12-09       Impact factor: 6.860

8.  Over-diagnosis of high-grade prostatic intraepithelial neoplasia: a prospective study of 251 cases.

Authors:  David G Bostwick; Jun Ma
Journal:  BJU Int       Date:  2007-11       Impact factor: 5.588

9.  Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Bora Gurel; M Scott Lucia; Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; Alan R Kristal; Howard L Parnes; Ashraful Hoque; Scott M Lippman; Siobhan Sutcliffe; Sarah B Peskoe; Charles G Drake; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-18       Impact factor: 4.254

10.  Chronic inflammation of the prostate type IV with respect to risk of prostate cancer.

Authors:  Antonio B Porcaro; Emanuele Rubilotta; Aldo Petrozziello; Claudio Ghimenton; Filippo Migliorini; Stefano Zecchini Antoniolli; Vincenzo Lacola; Carmelo Monaco; Pierpaolo Curti; Stefano Cavalleri; Romeo Pianon; Walter Artibani
Journal:  Arch Ital Urol Androl       Date:  2014-09-30
View more
  2 in total

1.  Next Generation Quality: Assessing the Physician in Clinical History Completeness and Diagnostic Interpretations Using Funnel Plots and Normalized Deviations Plots in 3,854 Prostate Biopsies.

Authors:  Michael Bonert; Ihab El-Shinnawy; Michael Carvalho; Phillip Williams; Samih Salama; Damu Tang; Anil Kapoor
Journal:  J Pathol Inform       Date:  2017-11-23

2.  The Microbiome of Prostate Fluid Is Associated With Prostate Cancer.

Authors:  Xiaowei Ma; Chenfei Chi; Liancheng Fan; Baijun Dong; Xiaoguang Shao; Shaowei Xie; Min Li; Wei Xue
Journal:  Front Microbiol       Date:  2019-07-19       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.